EGF and neoplasm: Recent investigation into how MenaINV contributes to tumor cell invasion and dissemination has focused on the ability of MenaINV to sensitize invading breast cancer cells to chemotactic or haptotactic signals such as EGF or fibronectin present in the ECM39, 43, 45, 51.